NCT06083831

Brief Summary

Circadian rhythms plays an important role for healthy. And critical illness contributes to the disruption of circadian rhythms. Not only right but also feeding can affect the circadian clock gene expression. In a investigators' previous study, some metabolic indicators (the albumin level, total cholesterol level and total bile acid level) and the increases in lymphocyte counts in the sequential feeding group were different from those in the continuous feeding group. Investigators think sequential feeding may adjust circadian clock gene expression for its effect on metabolism and immunity. Moreover, sequential feeding did alter the abundances of some gut microbes to some degree in the investigators' previous study. Investigators think sequential feeding may adjust gut flora rhythms.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 7, 2023

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

October 9, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 16, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

October 17, 2023

Status Verified

October 1, 2023

Enrollment Period

5 months

First QC Date

October 9, 2023

Last Update Submit

October 15, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • clock genes expression

    Genes including BMAL1 CLOCK TIMELESS PER1 and so on

    7 days feeding

  • Gut Flora Rhythm

    α diversity including shannon index and so on

    7 days feeding

Study Arms (2)

Sequential feeding group

After achieving ≥80% of the nutrition target calories (25-30 kcal/kg/d) by continuous feeding, continuous feeding was changed into intermittent feeding. The total daily dosage of enteral nutrition was equally distributed during three periods at 7-9:00, 11-13:00 and 17-19:00. The enteral nutritional suspension administered during each period was given at a uniform rate within two hours by an enteral feeding pump. The other times of the day were fasting times.

Other: feeding type

Continuous feeding group

Patients received continous feeding with a constant velocity by an enteral feeding pump over one day.

Other: feeding type

Interventions

In our department, the ICU patients received continuous feeding or sequential feeding. Patients received continuous feeding with a constant velocity by an enteral feeding pump over one day. In sequential feeding type, after achieving ≥80% of the nutrition target calories (25-30 kcal/kg/d), the patients received intermittent feeding. The total daily dosage of enteral nutrition was equally distributed during three periods at 7-9:00, 11-13:00 and 17-19:00. The enteral nutritional suspension administered during each period was given at a uniform rate within two hours by an enteral feeding pump. The other times of the day were fasting times.

Continuous feeding groupSequential feeding group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

ICU patients

You may not qualify if:

  • An estimated feeding time of less than 10 days in ICU;
  • Diabetes;
  • Gastrointestinal disease (gastrointestinal surgery, gastrointestinal bleeding, pancreatitis, Crohn's disease, ulcerative colitis, irritable bowel syndrome);
  • Inability to tolerate ≥80% of the nutrition target calories (25-30 kcal/kg/d) with enteral feeding through gastric tube;
  • The ability to eat orally at admission.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The affiliated hospital of qingdao university

Qingdao, Shandong, 266000, China

RECRUITING

MeSH Terms

Conditions

Feeding BehaviorCritical IllnessChronobiology Disorders

Condition Hierarchy (Ancestors)

Behavior, AnimalBehaviorDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsNervous System Diseases

Study Officials

  • bo yao, Dr.

    The Affiliated Hospital of Qingdao University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending physician

Study Record Dates

First Submitted

October 9, 2023

First Posted

October 16, 2023

Study Start

October 7, 2023

Primary Completion

March 1, 2024

Study Completion

May 1, 2024

Last Updated

October 17, 2023

Record last verified: 2023-10

Locations